Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients
Josephine C Ocran-Appiah, Céline Boutry, Caroline Hervé, Jyoti Soni et autres
us, be, in (code pays fourni par la source)